United States · FDA National Drug Code directory
Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 79739-6670_20dc9c68-50ed-4c48-a516-d5b82b3654a6
- Product NDC
- 79739-6670
- Form
- CAPSULE
- Composition / generic term
- Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate
- Labeler
- LGM PHARMA SOLUTIONS, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20040610
- Source listing expiry
- 20261231
Source-listed ingredients
- BUTALBITAL — 50 mg/1
- ACETAMINOPHEN — 325 mg/1
- CAFFEINE — 40 mg/1
- CODEINE PHOSPHATE — 30 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE, PLASTIC (79739-6670-1) · 79739-6670-1
- 500 CAPSULE in 1 BOTTLE, PLASTIC (79739-6670-5) · 79739-6670-5
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →